The New York Proton Center in East Harlem is the first and only proton therapy center in New York State, but often brings its ...
A systematic review of eight studies finds that higher prostate MRI quality shows inconsistent and very-low-certainty associations with the confirmation of clinically significant prostate cancer among ...
A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been ...
Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine ...
1d
Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance
Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine ...
A new study by the Medical University of Vienna found that a specialized form of imaging could identify 91% of prostate cancer cases without the need for a biopsy. Traditionally, a blood test can ...
Au-delà de sa mobilisation aux côtés d'Odysséa, le Crédit Agricole agit tout au long de l'année pour faire reculer le cancer.
A new theranostics suite is streamlining treatment and clinical trials for certain types of cancer, notably prostate cancer ...
PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.
Fagundes, MD, discussed when proton therapy is most justified over photon approaches in prostate cancer. In an interview with ...
A tracer originally designed to hunt prostate cancer is proving to be an unexpected ally in one of the world’s deadliest ...
L'une des principales agences américaines prévoit d'abaisser l'âge recommandé pour les mammographies, mais certains experts jugent cette décision insuffisante.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results